Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

hnRNP A0 Inhibitors

Inhibitors targeting hnRNP A0 belong to a class of chemical compounds designed to selectively modulate the activity of the heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0) protein. hnRNP A0 is a member of the hnRNP family, a group of RNA-binding proteins that play critical roles in the processing, transport, and regulation of pre-mRNA within the nucleus. These proteins are essential for the splicing of pre-mRNA into mature mRNA, and hnRNP A0, in particular, is involved in the formation of the spliceosome complex, which is responsible for accurately excising introns and joining exons during mRNA maturation. This process is vital for gene expression regulation and ensuring the production of functional proteins.

Inhibiting hnRNP A0 can be instrumental in studying the intricacies of pre-mRNA splicing and its regulatory mechanisms. Researchers use these inhibitors to dissect the role of hnRNP A0 in spliceosome assembly and function, as well as its interactions with other RNA-binding proteins and spliceosomal components. By manipulating hnRNP A0 activity, scientists gain insights into the molecular basis of alternative splicing, a phenomenon that generates multiple protein isoforms from a single gene and plays a significant role in cellular diversity and disease. Moreover, understanding hnRNP A0 inhibition can provide a better understanding of the broader hnRNP family's functions, offering potential avenues for research and insights into genetic diseases resulting from splicing abnormalities.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Antibiotic that can inhibit RNA polymerase in prokaryotes and, to a lesser extent, in eukaryotes, potentially affecting hnRNP A0 expression.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Inhibits DNA topoisomerase I, leading to DNA damage and potentially altering hnRNP A0 expression indirectly.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Intercalates with DNA and inhibits DNA topoisomerase II, which might influence hnRNP A0 mRNA synthesis.

Harringtonin

26833-85-2sc-204771
sc-204771A
sc-204771B
sc-204771C
sc-204771D
5 mg
10 mg
25 mg
50 mg
100 mg
$195.00
$350.00
$475.00
$600.00
$899.00
30
(1)

Inhibits protein synthesis at the level of translation elongation, which could indirectly decrease hnRNP A0 levels.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Causes premature termination of mRNA translation, potentially leading to reduced hnRNP A0 protein synthesis.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Cross-links DNA upon reductive activation, which could disrupt transcription and reduce hnRNP A0 expression.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$82.00
$300.00
$1082.00
30
(3)

Inhibits DNA polymerase and may indirectly reduce hnRNP A0 expression by causing a reduction in overall mRNA synthesis.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Inhibits peptide bond formation by binding to the 60S ribosomal subunit, potentially decreasing hnRNP A0 protein levels.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Terminates mRNA synthesis prematurely by acting as an adenosine analog, potentially decreasing hnRNP A0 mRNA levels.

Berberine

2086-83-1sc-507337
250 mg
$90.00
1
(0)

A plant alkaloid shown to have DNA intercalating properties, possibly altering transcription and affecting hnRNP A0 expression.